Forget October, Bring on the Rest of the Year

This month has been lousy, but there are factors that could still produce a year-end rally.

IBM's Pricey Red Hat Deal Helps Put Pep in Market's Step

There is much talk that IBM is overpaying for Red Hat, but this deal is a net positive for the market as a whole.

2 Plays on UnitedHealth Amid the Market Wreckage: Market Recon

This name has significantly outperformed both the S&P 500 and the health care sector over the course of this awful month

Be Ready to Ride the Dividend on Gilead Sciences

There are no catalysts to drive the stock price higher, so for now, Gilead is simply a cheap stock with a nice dividend.

Jim Cramer: Avoid the Naked CEOs When the Tide Goes Out

There is clear divergence between the best and the worst performers in each sector this earnings season.

Texas Instruments Exemplifies Drag of Lackluster Earnings on Market

There have been some solid earnings reports, but they haven't provided a boost to the broader market.

What Barclays Gets Wrong About Cannabis and Tobacco

Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.

Danaher Shares Rise After Higher Guidance, Beat on Earnings

Danaher reports its ninth straight earnings beat.

Jim Cramer: Wednesday Is a Watershed Day for Cannabis Stocks

But don't buy into this overheated market right as Canada legalizes, wait until prices come down -- which they will.

Stock Pickers Soon Should Find Values Amid Fear-Stoked Wreckage

Big-picture concerns are intensifying selling pressure, which favors bargain hunters in search of individual stocks.